Robert A. Rosenheck, M.D.

Article

Race and Long-Acting Antipsychotic Prescription at a Community Mental Health Center: A Retrospective Chart Review

April 15, 2012

Original Research

Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia

September 21, 2010

Original Research

Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia

August 10, 2010

Original Research

Use of Antipsychotics in the Treatment of Major Depressive Disorder in the U.S. Department of Veterans Affairs

May 5, 2009

Original Research

A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation

December 31, 2008

Original Research

Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: Diagnostic- and Symptom-Guided Drug Selection

June 30, 2008

Letter to the Editor

Aripiprazole and Perphenazine: No Difference

November 15, 2007

Educational Activity

Cost-Effectiveness Measures, Methods, and Policy Implications From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia

February 15, 2007

Academic Highlights

Practical Applications of Recent Antipsychotic Effectiveness Data.

January 15, 2007

Article

Underuse of Antidepressants in Major Depression: Prevalence and Correlates in a National Sample of Young Adults

August 31, 2000